Rezolute (RZLT) Cash from Financing Activities (2010 - 2026)

Rezolute's (RZLT) quarterly Cash from Financing Activities came in at $747000.0 in Q1 2026, up 7370.0% year-on-year from $10000.0 in Q1 2025, and up 109.83% quarter-over-quarter from $356000.0 in Q4 2025.

Rezolute (RZLT) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Rezolute has disclosed Cash from Financing Activities across 16 years of filings, most recently posting $747000.0 for Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at $747000.0, up 7370.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $103.2 million (up 48.47% YoY), and the FY2025 annual result was $107.3 million, up 70.28% from the prior year.
  • Cash from Financing Activities came in at $747000.0 for Q1 2026 at Rezolute, up from $356000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $101.2 million in Q2 2025 to a low of -$19000.0 in Q1 2022.
  • The 4-year median for Cash from Financing Activities is $829000.0 (2025), against an average of $23.2 million.
  • Across the five-year window, Cash from Financing Activities sank 83.44% in 2025 and surged 7370.0% in 2026, its largest moves.
  • Rezolute's Cash from Financing Activities stood at $11.6 million in 2022, then plunged by 94.32% to $657000.0 in 2024, then slumped by 45.81% to $356000.0 in 2025, then jumped by 109.83% to $747000.0 in 2026.
  • The last three Cash from Financing Activities figures came in at $747000.0 (Q1 2026), $356000.0 (Q4 2025), and $911000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Rezolute 520.13 Mn 520.13 Mn - 747,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 747,000.00
Mar 31, 2026 747,000.00
Dec 31, 2025 356,000.00
Dec 31, 2025 356,000.00
Sep 30, 2025 911,000.00
Sep 30, 2025 911,000.00
Jun 30, 2025 101.16 Mn
Jun 30, 2025 101.16 Mn
Mar 31, 2025 10,000.00
Mar 31, 2025 10,000.00
Dec 31, 2024 657,000.00
Dec 31, 2024 657,000.00
Sep 30, 2024 5.50 Mn
Sep 30, 2024 5.50 Mn
Jun 30, 2024 63.33 Mn
Jun 30, 2024 63.33 Mn
Mar 31, 2024 -3,000.00
Mar 31, 2024 -3,000.00
Sep 30, 2022 11.57 Mn
Sep 30, 2022 11.57 Mn